Detection and Management of Fever and Infection in the
Download
Report
Transcript Detection and Management of Fever and Infection in the
Detection and Management of
Fever and Infection in the CICU
John T. Berger, MD
Medical Director, Cardiac Intensive Care
Disclosures
• None Financial
• I am not an expert in infectious disease
• The only infection I know anything about is
critical pertussis
48,277 Cases
4994 < 1 year
20 deaths
16 < 1 year
Pulmonary Hypertension in Pertussis
PH seen in 75% of
patient who died
Leukoreduction in Critical Pertussis
• 14 Patients (11%)
– Exchange transfusion (12), leukopheresis (1), both (1)
– 8 had pulmonary hypertension detected
– 4 had treatment on study day 0
• No apparent survival benefit
Patients with WBC Count > 50K by leukoreduction status
Total
Survivors
Leukoreduction
13
8
No Leukoreduction
12
9
Objectives
• Outline the diagnostic dilemmas of
nosocomial infection and fever
• Discuss the rise and fall of procalcitonin as
biomarker for infection
Fever in the ICU
• Fever Prevalence 26-70%
– Etiology equally split between infectious and
noninfectious etiologies
• Prolonged fever more likely to be infection
• Fever a/w increased length of stay and
possibly mortality
• 737 Adult ICU Patients
– In septic patients, NSAIDS/Acetaminophen a/w
increased mortality (2-2.5 odds ratio) versus
non-septic patients with reduced mortality risk
(OR 0.22-0.58)
Lee et al. Crit Care 2012, 16:R33
Fever in the PICU
• PICU – Netherlands –
202 Children
– 40% with fever during
ICU stay
• Only ½ with infection
– Most within 48 hours of
admission
– Associated with
increased PICU length of
stay and mechanical
ventilation
• Gordjin et al. J Int Care
Med 2009
Fever ≠ Infection
• 3 mon old s/p TOF repair. Temp 38.8 C, WBC 15,000;
CXR unchanged
• How many would send cultures on day 1 before exam?
–
Blood, Urine, Tracheal Aspirate
• 66 post op febrile patients with blood cultures in 1st 48
hours
–
1 positive culture (staph epid)
• Kiragu PCCM 2009 10:364
• What about day 4?
• Fever “merits clinical assessment by a healthcare
professional… prior to any laboratory tests or imaging
procedures”
–
Am College of Crit Care Med 2008
Infectious
Sources of Fever Noninfectious
•
••
••
Meningitis
Otitis
Media
CLA-BSI
Sinusitis
Endocarditis
•
•
•
••
•
•
•
•
Ventilator
NEC
associated
•
•
Drugs
•
CAUTI
LRTI
•
•
Transfusion
Reactions
•
Pyelonephritis
PICC
or Site
Surgical
•
•
Endocrine
Disorders
•
Perineal
Femoral
BSI
Infectionor
(Adrenal insufficiency, •
perirectal
abscess
Cellulitis
thyrotoxicosis)
Arthritis
• Malignancy
Pressure Ulcer
• Inflammatory disorders
•
••
••
Brain Injury
Seizures
Infarction
CVA
Pulm
Embolus
ARDS
Pancreatitis
Pericarditis
Acalculous
Heart Failure
DVT
cholecystitis
Drug Eruptions
Ischemic
colitis
Environment, Low cardiac output, &
hyperthermia Wyndham. Ann NY Acad
Sci, 1977
Fever and Infection
• Adult Canadian (Calgary) ICUs
– 18,989 admissions
– Incidence of Fever fell from 50% to 25%
– No change in BSI rate, Abx consumption
• Niven et. al. CCM 2013, 41:1863
• CICU at CNMC
– 1 CLABSI and 1 CAUTI in last year
– Still lots of antibiotic use
Infection Related Ventilator
Associated Complications (IVACS)
(A name only the CDC could love)
• Most commonly diagnosed nosocomial infection
in PICU
• Incidence varies 0.3-45.1 / 1000 vent days
• Accounts for ½ antibiotic use in PICU
• Criteria for diagnosis neither sensitive or specific
• CDC: Infection a/w increase in vent settings
(PEEP by 2 cm H20 or Fio2 by 0.2)
Would you send a tracheal aspirate?
Start Antibiotics?
1. 4 mo old with RSV intubated for 3 days.
New 38.5 C fever, WBC =14,000, but no
change on CXR
2. 7 yo old intubated for 6 days for ARDS /
near drowning. New fever (38.9), WBC =
13,000 and no CXR changes
Tracheal Aspirates for IVAC
• Survey of 118 MDs in PALISI (98%
Attending)
• 65% -obtained tracheal aspirates as part of
a standard r/o sepsis work up
– 42% without a standard collection method
• “The RN or RT just does it”
Wilson PCCM
2014; 15:715
IVAC Treatment
Percentage who would prescribe Antibiotics
RSV
ARDS
Gram Stain –Few PMN, Few
GPC
2+MSSA, 2+PMN
34%
63%
79%
81%
2+MRSA, 2+PMN
81%
91%
2+ Pseudomonas, 2+PMN
80%
87%
Wilson PCCM
2014; 15:715
Tracheal Aspirates
• 335 samples from 61 intubated PICU
patients without regard for clinical status
– Predicted to be intubated for > 48 hours
– 42% post op CV surgery or cardiomyopathy
– None immunocompromised
• Culture results not provided to clinical team
• CDC Definition
– > 104 cfu/ml = positive Cx
– > 25 PMN / lpf
Willson et. al. PCCM 2014; 15:299
TA do not discriminate between
colonization and infection
In Line Suction 90%
% Patients with > 25 PMN/lpf
Single catheter 40%
Willson et. al. PCCM 2014; 15:299
40-90% Positive Cultures
• CDC Clinical Criteria did not correlate with
positive cultures
– Fever, WBCs, Increase Secretions, Worse
oxygenation, CXR changes
• Typical Pathogens isolated
– Staph A, Stenotrophamonas, Neisseria,
Klebsiella, and Staph E – 80% of cultures
Willson et. al. PCCM 2014; 15:299
What to do?
Procalcitonin
• Precursor protein of Calcitonin
• Usually undetectable in healthy humans
• Rises quickly in response to bacterial
infection (IL-6, TNF-α) and less response in
viral infection
• Initial studies suggested as method to guide
diagnose infection
• Suggestions that it is better discriminator
than CRP
Procalcitonin in PICU
• Single center study
• 64 of 225 eligible children with SIRS (25 with
bacterial infection)
• PCT and CRP drawn when found to have SIRS
• Infection adjudicated by blinded investigators
• Compared CRP to PCT
• 2.5 ng/ml PCT threshold
Simon PCCM 2008
Procalcitonin Variability
• High Inter-patient variability
• Increases seen with cardiopulmonary
bypass and other inflammatory states
• Use shifted to guide abx therapy
Schuetz et al.
Curr Opin CCM
2013
Procalcitonin after Cardiac Surgery
• 53 patients –All > 3 months, None Infected
• All significantly elevated for 3 days
Michalik Card in the Young 2006
Conclusions
• Fever common problem
• Diagnosis of infectious etiologies not as
straightforward as waiting for culture
results
• Antibiotic stewardship and rational
discontinuation remain important awaiting
the application of new biomarker strategies